SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

BRIEF-Unity Biotechnology Says Operating Loss For Q1 Was $14.9 Million

05/11/2021 08:10
BRIEF-Unity Biotechnology Says Operating Loss For Q1 Was $14.9 Million

- UNITY Biotechnology Inc UBX.O:

  • UNITY BIOTECHNOLOGY, INC. REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND BUSINESS UPDATES

  • UNITY BIOTECHNOLOGY INC - PHASE 2A PROOF-OF-CONCEPT STUDY INITIATED IN PATIENTS WITH DIABETIC MACULAR EDEMA; DATA EXPECTED FIRST HALF OF 2022

  • UNITY BIOTECHNOLOGY INC - CASH BALANCE SUFFICIENT TO FUND OPERATIONS INTO SECOND HALF OF 2022

  • UNITY BIOTECHNOLOGY - OPERATING LOSS FOR THREE MONTHS ENDED MARCH 31, 2021 WAS $14.9 MILLION COMPARED TO $27.2 MILLION FOR THREE MONTHS ENDED MARCH 31, 2020

Source text for Eikon: ID:nGNX4TvXbg

Further company coverage: UBX.O


(([email protected];))